Remel Recalls Yeastone Broth for Potential False Antifungal Susceptibility Results
Remel, Inc. is recalling Yeastone Broth because the product may report false susceptibility to antifungal agents, potentially affecting clinical testing.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The source identifies a Class II recall where the product may report false susceptibility to antifungal agents. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Remel, Inc. is recalling Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens. The affected lot, YY3462 lot 440400, did not meet specifications. The product may report false susceptibility to antifungal agents, specifically within the Azole family.
The recall involves 33 units in the United States and 54 units outside the United States. Distribution was worldwide, including nationwide distribution in the US states of Massachusetts and California, as well as in India, Saudi Arabia, and the UK.
Healthcare facilities and laboratories should stop using the affected product and contact Remel, Inc. for further instructions. Consumers are not directly affected as this is a professional medical device used in clinical settings.
The recalled product
- Product
- Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens
- Manufacturer
- Remel, Inc
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- YY3462 lot 440400 UDI-DI 848838018817
Distribution
Related recalls
Same manufacturer · Remel, Inc
See all →- HighGC Agar Base Culture Media Reduced Recovery of Neisseria gonorrhoeae
FDA (Devices) · 2026-07-08
- HighYeastone Broth recalled because it may report incorrect susceptibility results
FDA (Devices) · 2026-04-22
- SevereRemel Campy CVA Medium Lot Recalled Over Low Pathogen Recovery
FDA (Devices) · 2026-03-04
- ModerateCulture media recalled over contamination that may darken the broth
FDA (Devices) · 2025-12-03
- HighStrep Selective II Agar plates may carry Listeria monocytogenes contamination
FDA (Devices) · 2025-08-06
Same hazard · mis labeling
See all →- Moderate
- SevereHouse Foods Recalls Seitan Cubes Due to Missing Wheat Allergen Labeling
FDA (Food) · 2026-11-11
- ModerateSmith & Nephew Recalls Mislabelled Tibia Plate Implants
FDA (Devices) · 2026-11-11
- ModerateEthel's Gluten Free Turtle Dandy Dessert Bars Recalled for Labeling Errors
FDA (Food) · 2026-11-11
- HighCrystal Temptations Chocolatey Eyeballs Recalled for Undeclared Milk Allergen
FDA (Food) · 2026-11-11
Similar recalls
- HighYeastone Broth recalled because it may report incorrect susceptibility results
FDA (Devices) · 2026-04-22
- SevereMedical Diagnostic Plate Recalled for False Antibiotic Susceptibility Test Results
FDA (Devices) · 2022-12-14
- SevereMedical Device Recall: Sensititre Test Produces False Antibiotic Susceptibility Results
FDA (Devices) · 2022-12-14
- HighRemel VersaTREK Instrument Series 528 Recalled for False Positive Reports
FDA (Devices) · 2015-07-01
- CriticalSensititre Medical Device Recall: False Antibiotic Susceptibility Test Results
FDA (Devices) · 2022-12-14
- ModerateRemel TB Potassium Permanganate Stain Recalled for Performance Issues
FDA (Devices) · 2014-12-03